Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Illuminate the importance of extended RAS testing and other considerations for selecting systemic therapy in patients with metastatic colorectal cancer
Axel Grothey, MD
Mayo Clinic Cancer Center
- 0.75 Participation
- 0.81 Nurse
- 0.75 Pharmacist
- 0.75 Physician